Targeting Mitochondrial Function and Biogenesis in KRAS-Dependent Pancreatic Cancer

被引：0
|
作者：
Badejo, Adeleke Modupe [1 ]
McCreary, Jordan [3 ]
Szlavich, Ellyssa [3 ]
True, Heather [1 ]
Serrato, Ana [2 ]
Love, Quintin [1 ]
Malhotra, Ashim [1 ]
机构：
[1] Pacific Univ, Sch Pharm, Hillsboro, OR USA
[2] Pacific Univ, Hillsboro, OR USA
[3] Pacific Univ, Forest Grove, OR USA
来源：
FASEB JOURNAL | 2017年 / 31卷
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
823.7
引用
收藏
页数：1
相关论文
共 50 条
  • [11] Targeting Oncogenic KRAS in Pancreatic Cancer
    不详
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2017, 102 (04) : 569 - 569
  • [12] PANCREATIC CANCER Exosomes for targeting KRAS in the treatment of pancreatic cancer
    Buscail, Louis
    NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2017, 14 (11) : 636 - 637
  • [13] Targeting KRAS-dependent tumors with AZD4785, a high-affinity therapeutic antisense oligonucleotide inhibitor of KRAS
    Ross, Sarah J.
    Revenko, Alexey S.
    Hanson, Lyndsey L.
    Ellston, Rebecca
    Staniszewska, Anna
    Whalley, Nicky
    Pandey, Sanjay K.
    Revill, Mitchell
    Rooney, Claire
    Buckett, Linda K.
    Klein, Stephanie K.
    Hudson, Kevin
    Monia, Brett P.
    Zinda, Michael
    Blakey, David C.
    Lyne, Paul D.
    Macleod, A. Robert
    SCIENCE TRANSLATIONAL MEDICINE, 2017, 9 (394)
  • [14] Targeting ribosome biogenesis reinforces ERK-dependent senescence in pancreatic cancer
    Rowell, MC.
    Deschenes-Simard, X.
    Lopes-Paciencia, S.
    Le Calve, B.
    Mignacca, L.
    Kalegari, P.
    Fernandez-Ruiz, A.
    Guillon, J.
    Lessard, F.
    Bourdeau, V.
    Igelmann, S.
    Duman, AM.
    Stanom, Y.
    Kottakis, F.
    Deshpande, V.
    Krizhanovsky, V.
    Bardeesy, N.
    Ferbeyre, G.
    CELL CYCLE, 2023, 22 (19) : 2172 - 2193
  • [15] Tanshinone I attenuates proliferation and chemoresistance of cervical cancer in a KRAS-dependent manner
    Dun, Sidi
    Gao, Lan
    JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY, 2019, 33 (04)
  • [16] STK33 Kinase Activity Is Nonessential in KRAS-Dependent Cancer Cells
    Babij, Carol
    Zhang, Yihong
    Kurzeja, Robert J.
    Munzli, Anke
    Shehabeldin, Amro
    Fernando, Manory
    Quon, Kim
    Kassner, Paul D.
    Ruefli-Brasse, Astrid A.
    Watson, Vivienne J.
    Fajardo, Flordeliza
    Jackson, Angela
    Zondlo, James
    Sun, Yu
    Ellison, Aaron R.
    Plewa, Cherylene A.
    San Miguel, Tisha
    Robinson, John
    McCarter, John
    Schwandner, Ralf
    Judd, Ted
    Carnahan, Josette
    Dussault, Isabelle
    CANCER RESEARCH, 2011, 71 (17) : 5818 - 5826
  • [17] ARNTL2 is a Kras-dependent master regulator of hypoxic response in pancreatic ductal adenocarcinoma
    Maurer, H. Carlo
    Curiel-Garcia, Alvaro
    Laise, Pasquale
    Palermo, Carmine F.
    Sastra, Stephen A.
    Manji, Gulam A.
    Iuga, Alina
    Johnson, Kristen
    Genkinger, Jeanine
    Lyssiotis, Costas A.
    Califano, Andrea
    Olive, Kenneth P.
    CANCER RESEARCH, 2022, 82 (22) : 57 - 58
  • [18] BMAL2 is a KRAS-dependent master regulator of hypoxic response in pancreatic ductal adenocarcinoma
    Garcia, Alvaro Curiel
    Maurer, Carlo H.
    Hollinshead, Kate
    Laise, Pasquale
    Andren, Anthony
    Sastra, Stephen A.
    Palermo, Carmine F.
    Sagalovskiy, Irina R.
    Zhang, Li
    Holmstrom, Sam
    Johnson, Kristen
    Manji, Gulam A.
    Luga, Alina
    Lyssiotis, Costas A.
    Califano, Andrea
    Kimmelman, Alec
    Olive, Kenneth P.
    CANCER RESEARCH, 2023, 83 (07)
  • [19] KRAS-dependent cancer cells promote survival by producing exosomes enriched in Survivin
    Chang, Wen-Hsuan
    Nguyen, Thuy-Tien Thi
    Hsu, Chia-Hsin
    Bryant, Kirsten L.
    Kim, Hong Jin
    Ying, Haoqiang
    Erickson, Jon W.
    Der, Channing J.
    Cerione, Richard A.
    Antonyak, Marc A.
    CANCER LETTERS, 2021, 517 : 66 - 77
  • [20] KRAS-dependent suppression of MYC enhances the sensitivity of cancer cells to cytotoxic agents
    Ischenko, Irene
    Zhi, Jizu
    Hayman, Michael J.
    Petrenko, Oleksi
    ONCOTARGET, 2017, 8 (11) : 17995 - 18009
12345